ZIRCONIUM GIRENTUXIMAB SENVEDOXAM ZR-89

UNII:	9C40S99DV7
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ZIRCONIUM GIRENTUXIMAB SENVEDOXAM ZR-89
GSRS Full Record:	9C40S99DV7 i

2768427-84-3
Immunoglobulin G1, anti-(human antigen MN) (human-Mus musculus monoclonal cG250 γ1-chain), disulfide with human-Mus musculus monoclonal cG250 κ-chain, dimer, N6-[[11,22,33-tri(hydroxy-κO)-12,23,34-tri(oxo-κO)-1,4,15,26-tetraoxo-5,11,16,22,27,33-hexaazapentatriacont-1-yl]oxy]-L-lysine, complex with zirconium-89Zr
Zirconium (<sup>89</sup> Zr) Girentuximab Senvedoxam
Zirconium Girentuximab Senvedoxam Zr-89
Zirconium Zr 89 girentuximab deferoxamine
zirconium (89Zr) girentuximab senvedoxam [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZIRCONIUM GIRENTUXIMAB SENVEDOXAM ZR-89

Synonyms and Mappings

Resources